Dopaminergic drug therapy in patients with hyperprolactinemia that is difficult to treat.
Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Australia.
R J
RJ
Pepperell
D000236:Adenoma / Q000628:therapy; D015259:Dopamine Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004702:Endocrine Glands / Q000503:physiopathology; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D015663:Osteoporosis, Postmenopausal / Q000209:etiology / Q000517:prevention & control; D010911:Pituitary Neoplasms / Q000628:therapy
D015259:Dopamine Agents